$1.14/ day, billed weekly
Cancel anytime

(Ad-Free, Unlimited access)

NO CREDIT CARD REQUIRED

HSCSW

Heart Test Laboratories Inc. Warrant (HSCSW)

$0.07

Last Close (24-hour delay)

PASS

BUY Advisory
SELL Advisory (Profit)
SELL Advisory (Loss)

Profit
Loss
Pass (Skip investing)

Time period over

ALL
YEAR
MONTH
WEEK

Upturn Advisory Summary

09/15/2025: HSCSW (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock

Historic Profit -62.5%

Avg. Invested days 19

Today’s Advisory PASS

Upturn Star Rating

Upturn Advisory Performance

1.0

Stock Returns Performance

1.0

Profits based on simulation

Last Close 09/15/2025

Key Highlights

Company Size ETF	Market Capitalization 0 USD	Price to earnings Ratio -	1Y Target Price -
Price to earnings Ratio -	1Y Target Price -
Volume (30-day avg) -	Beta 2.58	52 Weeks Range 0.04 - 0.17	Updated Date 03/20/2025
52 Weeks Range 0.04 - 0.17	Updated Date 03/20/2025
Dividends yield (FY) -	Basic EPS (TTM) -1.09

Earnings Date

Report Date -

When -

Estimate -

Actual -

Profitability

Profit Margin -

Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -62.95%

Return on Equity (TTM) -163.47%

Valuation

Trailing PE -	Forward PE -	Enterprise Value -	Price to Sales(TTM) -
Enterprise Value -	Price to Sales(TTM) -
Enterprise Value to Revenue -	Enterprise Value to EBITDA -	Shares Outstanding -	Shares Floating 995735
Shares Outstanding -	Shares Floating 995735
Percent Insiders -	Percent Institutions -

About Heart Test Laboratories Inc. Warrant

Exchange NASDAQ	Headquaters Southlake, TX, United States
IPO Launch date 2022-06-15	CEO, President & Chairman of the Board of Directors Mr. Andrew Simpson
Sector Healthcare	Industry Medical Devices	Full time employees 15	Website https://heartsciences.com
Full time employees 15	Website https://heartsciences.com

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility. It is developing artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction and conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

https://www.upturn.io

Disclosure Privacy Policy Terms of Use Sitemap Contact Us

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.